| Highly potent triazole-based tubulin polymerization inhibitors Q Zhang, Y Peng, XI Wang, SM Keenan, S Arora, WJ Welsh Journal of medicinal chemistry 50 (4), 749-754, 2007 | 196 | 2007 |
| Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines S Arora, JM Yang, TG Kinzy, R Utsumi, T Okamoto, T Kitayama, PA Ortiz, ... Cancer research 63 (20), 6894-6899, 2003 | 127 | 2003 |
| Novel polymorphism in p21waf1/cip1 cyclin dependent kinase inhibitor gene: association with human esophageal cancer R Bahl, S Arora, N Nath, M Mathur, NK Shukla, R Ralhan Oncogene 19 (3), 323-328, 2000 | 90 | 2000 |
| Circulating p53 antibodies, p53 gene mutational profile and product accumulation in esophageal squamous‐cell carcinoma in India R Ralhan, S Arora, TK Chattopadhyay, NK Shukla, M Mathur International journal of cancer 85 (6), 791-795, 2000 | 81 | 2000 |
| Alterations in p53 and pRb pathways and their prognostic significance in oesophageal cancer R Mathew, S Arora, R Khanna, M Mathur, NK Shukla, R Ralhan European Journal of cancer 38 (6), 832-841, 2002 | 78 | 2002 |
| Antitumor Activity of New Substituted 3-(5-Imidazo[2,1-b]thiazolylmethylene)-2-indolinones and Study of Their Effect on the Cell Cycle A Andreani, M Granaiola, A Leoni, A Locatelli, R Morigi, M Rambaldi, ... Journal of medicinal chemistry 48 (17), 5604-5607, 2005 | 68 | 2005 |
| Novel microtubule polymerization inhibitor with potent antiproliferative and antitumor activity S Arora, XI Wang, SM Keenan, C Andaya, Q Zhang, Y Peng, WJ Welsh Cancer research 69 (5), 1910-1915, 2009 | 62 | 2009 |
| Identification of the ubiquitin-proteasome pathway in the regulation of the stability of eukaryotic elongation factor-2 kinase S Arora, JM Yang, WN Hait Cancer research 65 (9), 3806-3810, 2005 | 62 | 2005 |
| Identification of previously unrecognized antiestrogenic chemicals using a novel virtual screening approach CY Wang, N Ai, S Arora, E Erenrich, K Nagarajan, R Zauhar, D Young, ... Chemical research in toxicology 19 (12), 1595-1601, 2006 | 37 | 2006 |
| P-glycoprotein mediates resistance to histidine kinase inhibitors S Arora, JM Yang, R Utsumi, T Okamoto, T Kitayama, WN Hait Molecular pharmacology 66 (3), 460-467, 2004 | 33 | 2004 |
| High prevalence of p53 gene alterations and protein overexpression in human esophageal cancer: correlation with dietary risk factors in India. D Gaur, S Arora, M Mathur, N Nath, TK Chattopadhaya, R Ralhan Clinical cancer research: an official journal of the American Association …, 1997 | 32 | 1997 |
| Frequent alterations in the expression of tumor suppressor genes p16INK4A and pRb in esophageal squamous cell carcinoma in the Indian population R Ralhan, R Mathew, S Arora, R Bahl, NK Shukla, M Mathur Journal of cancer research and clinical oncology 126, 655-660, 2000 | 31 | 2000 |
| Alterations in cyclin D1 expression in esophageal squamous cell carcinoma in the Indian population R Mathew, S Arora, R Khanna, NK Shukla, M Mathur, R Ralhan Journal of cancer research and clinical oncology 127, 251-257, 2001 | 28 | 2001 |
| Esophageal squamous cell carcinomas with DNA replication errors (RER+) are associated with p16/pRb loss and wild-type p53 R Mathew, S Arora, M Mathur, TK Chattopadhyay, R Ralhan Journal of cancer research and clinical oncology 127, 603-612, 2001 | 26 | 2001 |
| Application of screening methods, shape signatures and engineered biosensors in early drug discovery process I Hartman, AR Gillies, S Arora, C Andaya, N Royapet, WJ Welsh, ... Pharmaceutical research 26, 2247-2258, 2009 | 25 | 2009 |
| Alterations in MDM2 expression in esophageal squamous cell carcinoma: relationship with p53 status S Arora, R Mathew, M Mathur, TK Chattopadhayay, R Ralhan Pathology Oncology Research 7, 203-208, 2001 | 25 | 2001 |
| Derivation of a prognostic equation to predict in-hospital mortality and requirement of invasive mechanical ventilation in patients with acute exacerbation of chronic … A Mohan, SP Bhatt, C Mohan, S Arora, TK Luqman-Arafath, R Guleria Indian J Chest Dis Allied Sci 50 (4), 335-42, 2008 | 24 | 2008 |
| Combretastatin A-4 and its analogs in cancer therapy S Arora, AF Gonzalez, K Solanki International Journal of Pharmaceutical Sciences Review and Research 22 (2), 168, 2013 | 22 | 2013 |
| Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways Y Peng, Q Zhang, S Arora, SM Keenan, S Kortagere, KM Wannemacher, ... Bioorganic & medicinal chemistry 17 (17), 6442-6450, 2009 | 20 | 2009 |
| Detection of anti-elongation factor 2 kinase (calmodulin-dependent protein kinase III) antibodies in patients with systemic lupus erythematosus S Arora, JM Yang, J Craft, W Hait Biochemical and biophysical research communications 293 (3), 1073-1076, 2002 | 12 | 2002 |
